Department of Medicine, University of California San Diego, La Jolla, California, USA.
Institute of Medicine, Department of Molecular and Clinical Medicine and Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI137689.
Dysregulated protein degradative pathways are increasingly recognized as mediators of human disease. This mechanism may have particular relevance to desmosomal proteins that play critical structural roles in both tissue architecture and cell-cell communication, as destabilization/breakdown of the desmosomal proteome is a hallmark of genetic-based desmosomal-targeted diseases, such as the cardiac disease arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). However, no information exists on whether there are resident proteins that regulate desmosomal proteome homeostasis. Here, we uncovered a cardiac constitutive photomorphogenesis 9 (COP9) desmosomal resident protein complex, composed of subunit 6 of the COP9 signalosome (CSN6), that enzymatically restricted neddylation and targeted desmosomal proteome degradation. CSN6 binding, localization, levels, and function were affected in hearts of classic mouse and human models of ARVD/C affected by desmosomal loss and mutations, respectively. Loss of desmosomal proteome degradation control due to junctional reduction/loss of CSN6 and human desmosomal mutations destabilizing junctional CSN6 were also sufficient to trigger ARVD/C in mice. We identified a desmosomal resident regulatory complex that restricted desmosomal proteome degradation and disease.
蛋白质降解途径失调被认为是人类疾病的重要介质。这一机制可能与桥粒蛋白密切相关,桥粒蛋白在组织架构和细胞间通讯中起着关键的结构作用,因为桥粒蛋白组的不稳定/破坏是基于遗传的桥粒靶向疾病的特征,如心律失常性右室发育不良/心肌病(ARVD/C)。然而,目前尚不清楚是否存在调节桥粒蛋白组稳态的固有蛋白。在这里,我们发现了一种心脏组成型光形态发生 9(COP9)桥粒固有蛋白复合物,由 COP9 信号体的亚基 6(CSN6)组成,该复合物具有酶限制的 neddylation 和靶向桥粒蛋白组降解的作用。在经典的 ARVD/C 小鼠和人类模型的心脏中,分别受桥粒缺失和突变影响,CSN6 的结合、定位、水平和功能均受到影响。由于 CSN6 的连接减少/丢失以及破坏连接 CSN6 的人类桥粒突变导致桥粒蛋白组降解失去控制,也足以在小鼠中引发 ARVD/C。我们鉴定了一种桥粒固有调节复合物,该复合物限制桥粒蛋白组的降解和疾病的发生。